Discover the Evexia advantage Start ordering today
Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.
Register Now86356; 86357; 86359; 86360
Overview:
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).
Bakesi JG, Grenier K, Roboz J, et al. CD8 lymphocyte subsets provide prognostic measure of HIV disease progression. Int Conf AIDS. 1990; 6:218. Abstract SB 528.
Grenier K, Bach BA, Campbell D, et al. Discordant expression of T-cell activation markers (HLA-DR, CD38, CD25, CD69) as indicators of cellular immune response to HIV infection. Int Conf AIDS. 1990; 6:141. Abstract SA 237.
Collection Instructions:
Lavender-top (EDTA) tube and yellow-top (ACD-A) or (ACD-B) tube.
Invert tube 8 to 10 times immediately after collection. To preserve cellular viability, draw specimen so it will arrive in the laboratory within 48 hours of collection. Indicate date and time of venipuncture on the tube(s) and on the test request form.
Maintain specimen at room temperature. Do not freeze or refrigerate.
Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.
Register Now